Wright Mecal
Wright Medical Announces Fundamental Change With Respect to the 2.25% Cash Convertible Senior Notes due 2021 issued by Wright Medical Group N.V. and the 1.625% Cash Exchangeable Senior Notes due 2023 issued by Wright Medical Group, Inc.
AMSTERDAM, The Netherlands, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Wright Medical today announced that in connection with the tender offer (the “Tender Offer”) and the mergers (the “Mergers”) pursuant to which Wright Medical Group N.V. (“WMG”) was acquired by Stryker Corporation, Stryker Unite, Ltd. (formerly Wright Medical Ltd.) succeeded to and assumed any and all obligations of WMG under the indentures governing the 2.25% Cash Convertible Senior Notes due 2021 issued by WMG (the “2021 Notes”) and the 1.625% Cash Convertible Senior Notes due 2023 issued by Wright Medical Group, Inc. (the “2023 Notes”). In connection with the closing of the Mergers, the name of Wright Medical Ltd. (as successor to WMG) was changed to Stryker Unite, Ltd. Pursuant to the indentures governing the 2021 Notes and the 2023 Notes, the consummation of the Tender Offer and the related securities filing made in connection with the Tender Offer, and the consummation of each of the Mergers, each constituted a “Fundamental Change” and a “Make-Whole Fundamental Change” under, and as defined in, such indentures. The “Effective Date” (as defined in each indenture) of the Fundamental Change and Make-Whole Fundamental Change in connection with each of the Mergers was November 11, 2020 and in connection with the Tender Offer was November 12, 2020. The “Fundamental Change Repurchase Date” (as defined in each indenture) will be December 8, 2020. In connection with the Make-Whole Fundamental Change, the conversion rate of the 2021 Notes will be adjusted to 47.4849, and the exchange rate of the 2023 Notes will be adjusted to 34.5507, in each case for any conversions between November 11, 2020 and December 7, 2020. In connection with the Mergers, the “Reference Property” per ordinary share of WMG, under and as defined in each Indenture, will be $30.75.Investors & Media:Julie D. Dewey, IRC Sr. Vice President, Chief Communications Officer Wright Medical Group N.V. (901) 290-5817 [email protected]
GlobeNewswire · 11/12/2020 21:05
Wright Medical Group N.V. (NASDAQ:WMGI) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
As you might know, Wright Medical Group N.V. (NASDAQ:WMGI) just kicked off its latest third-quarter results with some...
Simply Wall St. · 11/06/2020 18:12
Wright Medical Group N.V. (NASDAQ:WMGI) Shares Could Be 43% Below Their Intrinsic Value Estimate
How far off is Wright Medical Group N.V. (NASDAQ:WMGI) from its intrinsic value? Using the most recent financial data...
Simply Wall St. · 11/04/2020 18:40
Stryker to divest certain assets to get FTC blessing on Wright Medical deal
The U.S. Federal Trade Commission ((FTC)) is requiring Stryker ([[SYK]] +1.8%) to sell its total ankle replacement and finger joint implant assets in order to receive agency approval for its $4B
Seekingalpha · 11/03/2020 16:31
What Does Wright Medical Group's Debt Look Like?
Over the past three months, shares of Wright Medical Group (NASDAQ: WMGI) moved higher by 2.20%. Before we understand the importance of debt, let us look at how much debt Wright Medical Group has.Wright Medical Group's Debt Based on Wright Medical Group's balance sheet as of July 29, 2020, long-term debt is at $756.83 million and current debt is at $454.34 million, amounting to $1.21 billion in total debt. Adjusted for $133.65 million in cash-equivalents, the company's net debt is at $1.08 billion.Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.Investors look at the debt-ratio to understand how much financial leverage a company has. Wright Medical Group has $2.56 billion in total assets, therefore making the debt-ratio 0.47. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 25% might be higher for one industry and normal for another.Why Debt Is Important Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more.See more from Benzinga * Click here for options trades from Benzinga * A Look Into Stryker's Debt * SAP's Debt Overview(C) 2020 Benzinga does not provide investment advice. All rights reserved.
Benzinga · 10/26/2020 12:49
Integra LifeSciences Bails Out Of A Once-Promising Growth Opportunity
Integra and Smith & Nephew announced a deal wherein Smith & Nephew will acquire Integra's orthopedic extremities business for $240 million in cash.Integra's cobbled-together extremities portfolio could never make much headway, squeezed between better-established leaders and aggressive and innovative startups.Management would do well to focus future M&A on targets closer to its core specialties in neuro and wound care.Integra looks a little undervalued, but it can be difficult for mid-cap med-techs to stand out without double-digit revenue growth.
Seekingalpha · 10/01/2020 00:09
How Much Is Wright Medical Group N.V. (NASDAQ:WMGI) Paying Its CEO?
Bob Palmisano has been the CEO of Wright Medical Group N.V. (NASDAQ:WMGI) since 2011, and this article will examine...
Simply Wall St. · 09/18/2020 13:45
Wright Medical (WMGI): Hedge Fund Interest Inching Up
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of June 30th, when the S&P 500 Index
Insider Monkey · 09/10/2020 02:47
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of WMGI. Analyze the recent business situations of Wright Mecal through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts


Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average WMGI stock price target is 30.47 with a high estimate of 31.00 and a low estimate of 29.00.
Institutional Holdings
Institutions: 368
Institutional Holdings: 147.90M
% Owned: 113.82%
Shares Outstanding: 129.93M
Sold Out
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Medical Equipment, Supplies & Distribution
Healthcare Equipment & Supplies
Key Executives
Non-Executive Chairman/Independent Director
David Stevens
President/Chief Executive Officer/Executive Director
Robert Palmisano
Chief Financial Officer/Chief Operating Officer/Executive Vice President
Lance Berry
Corporate Executive
Peter Cooke
Senior Vice President/Chief Compliance Officer
J. Wesley Porter
Corporate Executive
Patrick Fisher
Corporate Executive
Timothy Lanier
Senior Vice President/IR Contact Officer
Julie Tracy
Corporate Executive
Steven Wallace
Chief Human Resource Officer/Senior Vice President
Andrew Morton
Executive Vice President
Kevin Cordell
Senior Vice President - Finance
Julie Andrews
Senior Vice President/IR Contact Officer
Julie Tracy Dewey
Senior Vice President/IR Contact Officer
Julie D Dewey
Senior Vice President/Chief Compliance Officer
J. Porter
Senior Vice President/General Counsel/Secretary
James Lightman
Senior Vice President/IR Contact Officer
Julie Dewey
Senior Vice President
Jason Asper
Senior Vice President
Barry Regan
Senior Vice President
Kevin Smith
Senior Vice President
Jennifer Walker
Non-Executive Independent Director
Gary Blackford
Non-Executive Independent Director
James Mackin
Non-Executive Independent Director
John Miclot
Non-Executive Independent Director
Kevin O'Boyle
Non-Executive Independent Director
Amy Paul
Non-Executive Independent Director
Richard Wallman
Non-Executive Independent Director
Elizabeth Weatherman
No Data

Webull offers kinds of Wright Mecal stock information, including NASDAQ:WMGI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WMGI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading WMGI stock methods without spending real money on the virtual paper trading platform.